Press release
Lopinavir/Ritonavir Market Trends, Business Overview, Industry Growth and Forecast to 2028
The global lopinavir/ritonavir market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The combination of lopinavir and ritonavir is used with other drugs to treat human immunodeficiency HIV infection and other types of cancer. The rising prevalence of the HIV along with the development of advanced treatment options is a key factor driving the growth of the global lopinavir/ritonavir market. According to the World Health Organization (WHO), in 2019 there were approximately 38 million people worldwide living with HIV. Moreover, 36.2 million were adults and 1.8 million were children below 15 years old.The cohesive government policies is further contributing to the market growth. For instance, in 2020 after the Israeli government approved the licensing of the common Kaletra HIV anti-coronavirus pill, AbbVie Inc. agreed to allow the country to purchase copycat versions of its drug from foreign suppliers, a rare occurrence in which the threat of compulsory licensing drug additive access. In addition, the growing focus of pharmaceutical companies on additional treatment options, and increased awareness are factors that will increase the global market for lopinavir/ritonavir.
According to NCBI research, the lopinavir/ritonavir is the first and only compound HIV-1 protease inhibitor and they do major clinical trials have demonstrated the clinical efficacy of lopinavir/ritonavir in both patients with antiretroviral-naïve and in-knowledge. The immunologic and virologic benefits of treatment with this agent have been proven in adults with HIV, adolescents, and children. Little research supports the use of lopinavir/ritonavir monotherapy as a treatment for some patients. The drug is characterized by a large genetic resistance and appears to be more tolerant of adherence than previous, undeveloped PIs.
In 2020 Cipla NSE 0.45% has received approval from the US healthcare provider USFDA for Lopinavir and oral Ritonavir tablets used to treat AIDS in infants and toddlers. Its Approval by US Food and Drug Administration (USFDA) for a new formulation to take Lopinavir / Ritonavir 40mg / 10 mg oral pellets to Cipla. Such approvals are expected to drive the market growth.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Lopinavir/Ritonavir Market at: https://orionmarketreports.com/request-sample/?id=92649&submit=Request+Sample%0D%0A
Market Coverage
•The market number available for - 2021-2028
•Base year- 2021
•Forecast period- 2022-2028
•Segment Covered-
•By Type
•By Application
•By Distribution Channel
•Regions Covered-
•North America
•Europe
•Asia-Pacific
•Rest of the World
Competitive Landscape- AbbVie Inc., Merck & Co., Inc., GlaxoSmithKline plc, Sanofi SA, and Pfizer Inc., and Cipla Inc. among others.
A full report Lopinavir/Ritonavir Market of is available at: https://orionmarketreports.com/lopinavir-ritonavir-market/92649/
Global Lopinavir/Ritonavir Market Report by Segment
By Type
•Antiretroviral
•Protease Inhibitor (Anti-HIV)
By Application
•Adult
•Children
By Distribution Channel
•Hospital Pharmacy
•Retail Pharmacy
•Online Pharmacy
Key questions addressed by the report
•What is the market growth rate?
•Which segment and region dominate the market in the base year?
•Which segment and region will project the fastest growth in the market?
•How has COVID-19 impacted the market?
•Deviation from the pre-COVID-19 forecast
•Most affected region and segment
•Who is the leader in the market?
•How players are addressing challenges to sustain growth?
•Where is the investment opportunity?
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lopinavir/Ritonavir Market Trends, Business Overview, Industry Growth and Forecast to 2028 here
News-ID: 2586259 • Views: …
More Releases from Orion Market Research
Orthopedic Implants Market Size Analysis, Competitive Insights, Leading Players …
The global Orthopedic Implants Market was valued at approximately USD 55.90 billion in 2024 and is projected to reach USD 80.80 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.14% from 2025 to 2033.
Orthopedic Implants Market Overview
The Orthopedic Implants Market is witnessing steady growth, driven by the rising prevalence of musculoskeletal disorders, including arthritis, fractures, and osteoporosis. Technological advancements in implant materials, such as titanium…
Healthcare Cybersecurity Market Set to Witness Significant Growth by 2033 | IBM …
The global Healthcare Cybersecurity Market was valued at approximately USD 15.03 billion in 2024 and is projected to reach USD 65.67 billion by 2033, growing at a compound annual growth rate (CAGR) of 17.80% from 2024 to 2033.
Healthcare Cybersecurity Market Overview
The Healthcare Cybersecurity Market is witnessing rapid growth due to the increasing adoption of digital technologies in healthcare, including electronic health records (EHRs), telemedicine, and connected medical devices. Rising…
Dental Polishing Machine Market: A Guide to Understanding the Process
The global Dental Polishing Machine Market was valued at approximately USD 3.33 billion in 2024 and is projected to reach USD 6.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2033.
Dental Polishing Machine Market Overview
The Dental Polishing Machine Market is experiencing steady growth, driven by increasing demand for aesthetic dental treatments and preventive oral care. These machines are essential in dental…
Artificial Intelligence (AI) in Life Science Analytics Market Set to Witness Sig …
The global Artificial Intelligence (AI) in Life Science Analytics Market was valued at approximately USD 2.22 billion in 2024 and is projected to reach USD 6.28 billion by 2034, growing at a compound annual growth rate (CAGR) of 10.96% from 2025 to 2033.
Artificial Intelligence (AI) in Life Science Analytics Market Overview
The Artificial Intelligence (AI) in Life Science Analytics Market is experiencing rapid growth as AI technologies revolutionize data analysis…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
